Patients' Risk Tolerance for Non-Dietary Therapies in Celiac Disease

Area of Science:

• Immunology
• Gastroenterology

Background:

• Celiac disease (CD) is an autoimmune disorder caused by an immune response to gluten.
• It primarily affects the small intestine, leading to inflammation, malabsorption, and systemic effects.
• Current management relies solely on a strict gluten-free diet.

Purpose of the Study:

• To review the development of novel non-dietary therapies for celiac disease.
• To address the limitations and burdens associated with the gluten-free diet.
• To explore emerging treatment options beyond dietary restrictions.

Main Methods:

• Literature review of recent advancements in celiac disease therapeutics.
• Analysis of research on non-dietary treatment strategies.
• Synthesis of information on patient-reported outcomes and treatment satisfaction.

Main Results:

• Significant growth in the development of novel non-dietary therapies for CD.
• Emerging therapies aim to mitigate the effects of gluten exposure or modulate the immune response.
• Patient dissatisfaction with the gluten-free diet fuels the search for alternatives.

Conclusions:

• Novel non-dietary therapies show promise for managing celiac disease.
• These advancements offer potential alternatives or adjuncts to the gluten-free diet.
• Further research is needed to establish the efficacy and safety of new treatments.